BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3626051)

  • 1. [Nonsecretory myeloma with t(14;18)(q32;21) chromosome abnormality].
    Fujii H; Maekawa T; Kanoh T; Ohnaka T; Kamezaki H; Nishida K; Urata Y
    Rinsho Ketsueki; 1987 Apr; 28(4):601-7. PubMed ID: 3626051
    [No Abstract]   [Full Text] [Related]  

  • 2. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
    Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
    Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation (11;14)(q13;q32) and partial trisomy 1q in a case of multiple myeloma.
    Kwong YL; Lie AK; Chan LC
    Am J Hematol; 1993 Nov; 44(3):212-3. PubMed ID: 8213777
    [No Abstract]   [Full Text] [Related]  

  • 4. The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome.
    Vekemans MC; Lemmens H; Delforge M; Doyen C; Pierre P; Demuynck H; Bries G; Lemmens J; Meeus P; Straetmans N; Bauwens D; Vidrequin S; Rack K; Vandenberghe P; Wlodarska I; Michaux L
    Br J Haematol; 2010 Jun; 149(6):901-4. PubMed ID: 20148877
    [No Abstract]   [Full Text] [Related]  

  • 5. IgM myeloma with t(4;14)(p16;q32).
    Ackroyd S; O'Connor SJ; Rawstron AC; Owen RG
    Cancer Genet Cytogenet; 2005 Oct; 162(2):183-4. PubMed ID: 16213370
    [No Abstract]   [Full Text] [Related]  

  • 6. t(1:3)(q10;p10) and chromosome 7 abnormality associated with the progression of multiple myeloma.
    Toubai T; Tanaka J; Higa T; Iwao N; Shigematsu A; Kato N; Watanabe K; Sudo J; Kasai M; Imamura M
    Clin Lab Haematol; 2005 Oct; 27(5):355-6. PubMed ID: 16178923
    [No Abstract]   [Full Text] [Related]  

  • 7. [A 14q+ marker chromosome due to t(11;14) in a case of nonsecretory plasma cell leukemia].
    Fukushima Y; Miura I; Niitsu H; Hashimoto K; Takatsu H; Akihama T; Miura A
    Rinsho Ketsueki; 1986 Nov; 27(11):2124-30. PubMed ID: 3820630
    [No Abstract]   [Full Text] [Related]  

  • 8. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
    Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
    Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia.
    Kubonishi I; Seto M; Shimamura T; Enzan H; Miyoshi I
    Cancer; 1992 Sep; 70(6):1528-35. PubMed ID: 1516003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32).
    Akiyama N; Tsuruta H; Sasaki H; Sakamoto H; Hamaguchi M; Ohmura Y; Seto M; Ueda R; Hirai H; Yazaki Y
    Cancer Res; 1994 Jan; 54(2):377-9. PubMed ID: 8275473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in multiple myeloma: it's in the genes.
    Bergsagel PL
    Clin Cancer Res; 2003 Feb; 9(2):533-4. PubMed ID: 12576415
    [No Abstract]   [Full Text] [Related]  

  • 12. Mott cells in CD20-positive myeloma.
    Ramasamy K; Ladon D; Salisbury J; Ireland R
    Br J Haematol; 2011 Feb; 152(4):366. PubMed ID: 21265822
    [No Abstract]   [Full Text] [Related]  

  • 13. [Close correlations between CD20 expression, a small mature plasma cell morphology and t(11 ; 14) in multiple myeloma].
    Matsuda I; Mori Y; Nakagawa Y; Sawanobori M; Uemura N; Suzuki K
    Rinsho Ketsueki; 2005 Dec; 46(12):1293-7. PubMed ID: 16447802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts.
    Malgeri U; Baldini L; Perfetti V; Fabris S; Vignarelli MC; Colombo G; Lotti V; Compasso S; Bogni S; Lombardi L; Maiolo AT; Neri A
    Cancer Res; 2000 Aug; 60(15):4058-61. PubMed ID: 10945609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients.
    Stralen E; Leguit RJ; Begthel H; Michaux L; Buijs A; Lemmens H; Scheiff JM; Doyen C; Pierre P; Forget F; Clevers HC; Bast B
    Leukemia; 2009 Apr; 23(4):801-3. PubMed ID: 18830254
    [No Abstract]   [Full Text] [Related]  

  • 17. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
    Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
    Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H; Facon T; Daviet A; Godon C; Rapp MJ; Harousseau JL; Grosbois B; Bataille R
    Cancer Res; 1999 Sep; 59(18):4546-50. PubMed ID: 10493504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
    Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
    Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duplication of chromosome arms 9q and 11q: evidence for a novel, 14q32 translocation-independent pathogenetic pathway in multiple myeloma.
    Liebisch P; Scheck D; Erné SA; Wellmann A; Wendl C; Janczik S; Kolmus S; Kröber A; Einsele H; Straka C; Goldschmidt H; Benner A; Stilgenbauer S; Döhner H
    Genes Chromosomes Cancer; 2005 Jan; 42(1):78-81. PubMed ID: 15390182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.